Skip to main content
. 2022 Apr 20;13:836635. doi: 10.3389/fphar.2022.836635

FIGURE 3.

FIGURE 3

Distribution of sputum granulocyte-predominant subtypes in the type 2 biomarker-classified subgroups. Of successful sputum induction, 75 adequate sputum samples were examined. Patients were divided into four subtypes according to the cutoff values of sputum eosinophilia (≥2.7%) and predominant neutrophil (≥50.0%). Values were analyzed using Fisher’s exact test. In the FeNOlo/B-EOSlo subgroup, the eosinophil-predominant, mixed-granulocyte, neutrophil-predominant, and paucigranulocyte subtypes were as follows: 5.9, 0.0, 52.9, and 41.2%, respectively. In the FeNOhi/B-EOSlo subgroup: 46.7, 13.3, 26.7, and 13.3%, respectively. In the FeNOlo/B-EOShi subgroup: 33.3, 14.3, 14.3, and 38.1%, respectively. In the FeNOhi/B-EOShi subgroup: 68.2, 4.5, 18.2, and 9.1%, respectively. FeNOlo, low FeNO; FeNOhi, high FeNO; B-EOSlo, low B-EOS; B-EOShi, high B-EOS. *, significantly high or low, compared with the other FeNO/B-EOS subgroups.